Physician profile
Michael H Culig
NPI 1801872585
$1,439.06
in general payments reported to CMS, 2019-2025
13 companies · $17.78 in 2025
The $17.78 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $306 · 2020: $34.95 · 2021: $229 · 2022: $417 · 2023: $326 · 2024: $109 · 2025: $17.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $453.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $452.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $412.79 | 2019-2024 | |
| Abiomed | $162.68 | 2021-2025 | Impella |
| Edwards Lifesciences Corporation | $160.72 | 2022-2023 | |
| Boston Scientific Corporation | $135.22 | 2022 | |
| Janssen Pharmaceuticals, INC | $104.92 | 2021 | |
| Zimmer Biomet Holdings, INC. | $104.45 | 2023 | Sternalock Blu System |
| Ethicon US, LLC | $100.02 | 2019 | |
| Getinge USA Sales, LLC | $74.46 | 2020-2023 | Vasoview Hemopro 2 |
| Livanova USA, INC. | $64.38 | 2019-2022 | |
| Smith+Nephew, INC. | $47.13 | 2022 | |
| Abbott Laboratories | $44.02 | 2019-2020 | |
| Corcym INC | $14.28 | 2021 | |
| Integra Lifesciences Corporation | $13.99 | 2024 | Codman Certas, Codman Hakim, Cusa Clarity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Culig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.